Impact of dose feasibility on the conduct of phase I trials of adoptive cell therapy

Background: /Aims: In early-phase cell therapy trials, each dose level being studied is defined by the number of cells infused into the trial participant. The issue of dose feasibility presents itself when the desired number of cells is not reached in the expansion process. Consequently, dose assign...

書目詳細資料
發表在:	Contemporary Clinical Trials Communications
Main Authors:	Evan M. Bagley, Nolan A. Wages
格式:	Article
語言:	英语
出版:	Elsevier 2022-02-01
主題:	Phase I Dose feasibility Algorithmic designs Cell therapy Dose finding
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2451865421001770

相似書籍

A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation
由: Jin Xu, et al.
出版: (2022-10-01)

Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials
由: Richard Brown, et al.
出版: (2025-03-01)

Target toxicity design for phase I dose-finding
由: Wenchuan Guo, et al.
出版: (2021-04-01)

Assessing the reporting quality of early phase dose-finding trial protocols: a methodological reviewResearch in context
由: Guillermo Villacampa, et al.
出版: (2023-06-01)

Concurrent dose-finding of a novel cancer drug with and without a second agent
由: Nolan A. Wages, et al.
出版: (2023-01-01)

Optimal biological dose: a systematic review in cancer phase I clinical trials
由: J. Fraisse, et al.
出版: (2021-01-01)

A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
由: Zhaohang Li, et al.
出版: (2023-03-01)

Interval design to identify the optimal biological dose for immunotherapy
由: Yeonhee Park
出版: (2022-12-01)

Patient and public involvement and engagement in the development of innovative patient-centric early phase dose-finding trial designs
由: Emily Alger, et al.
出版: (2024-06-01)

Two-dimensional calibration-free odds design for phase I drug-combination trials
由: Wenliang Wang, et al.
出版: (2023-11-01)

TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis
由: M. Cole, et al.
出版: (2021-07-01)

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsResearch in context
由: Moreno Ursino, et al.
出版: (2025-01-01)

CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsResearch in context
由: Jan Rekowski, et al.
出版: (2025-01-01)

Three steps toward dose optimization for oncology dose finding
由: Jason J.Z. Liao, et al.
出版: (2024-08-01)

Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study
由: Olga Solovyeva, et al.
出版: (2023-07-01)

Determination of the 50% and 95% effective dose of esketamine combined with propofol for intravenous sedation in pediatric circumcision: study protocol for a randomized controlled, double-blind, dose-finding clinical trial
由: Junqin Mao, et al.
出版: (2025-10-01)

Implementing the EffTox dose-finding design in the Matchpoint trial
由: Kristian Brock, et al.
出版: (2017-07-01)

Revisiting dose-finding of monoclonal antibodies in migraine
由: Linda Al-Hassany, et al.
出版: (2023-06-01)

Phase I clinical trial designs in oncology: A systematic literature review from 2020 to 2022
由: Ning Li, et al.
出版: (2024-01-01)

Adjusting perioperative methadone dose for elderly and fragile hip fracture patients (MetaHip-trial) – A statistical analysis plan for an adaptive dose-finding trial
由: Andreas Kristian Pedersen, et al.
出版: (2023-12-01)

Linear accelerator selection: Impact on feasibility dose-volume histograms and practicality in dose reduction for organs at risk during prostate volumetric-modulated arc therapy
由: Motoharu Sasaki, et al.
出版: (2025-10-01)

Determination of maximum tolerated dose and toxicity of Inauhzin in mice
由: Qi Zhang, et al.
出版: (2015-01-01)

Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples
由: Erik van Werkhoven, et al.
出版: (2020-06-01)

The EC90 of remifentanil for inhibiting endotracheal intubation responses under anesthesia induction with ciprofol: study protocol for a dose-finding trial with the biased-coin design
由: Jianing Guo, et al.
出版: (2024-08-01)

Reporting quality of dose-expansion cohorts in trials of anticancer drugs could be improved: a cross-sectional study
由: Yafang Huang, et al.
出版: (2025-06-01)

Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study
由: B. Salas, et al.
出版: (2024-03-01)

Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity
由: Wenyun Yang, et al.
出版: (2023-11-01)

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable
由: Christina Yap, et al.
出版: (2024-10-01)

Systematic comparison of the statistical operating characteristics of various Phase I oncology designs
由: Revathi Ananthakrishnan, et al.
出版: (2017-03-01)

A nonparametric Bayesian continual reassessment method in single-agent dose-finding studies
由: Niansheng Tang, et al.
出版: (2018-12-01)

Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions
由: Joshuaine Grant, et al.
出版: (2023-12-01)

A comprehensive comparison of phase I dose escalation methods
由: Efehan Ulas, et al.
出版: (2018-11-01)

MC-Keyboard: A Practical Phase I Trial Design for Targeted Therapies and Immunotherapies Integrating Multiple-Grade Toxicities
由: Liyun Jiang, et al.
出版: (2024-08-01)

Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological reviewResearch in context
由: Emily Alger, et al.
出版: (2023-10-01)

The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
由: Dan‐Dan Tan, et al.
出版: (2023-09-01)

The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design
由: John Benest, et al.
出版: (2022-10-01)

Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design
由: Keppel Hesselink JM, et al.
出版: (2017-03-01)

Effective concentration (EC50) of sevoflurane for intraocular pressure measurement in anaesthetised children with glaucoma: A dose-finding study
由: Elayavel Ravichandran, et al.
出版: (2024-01-01)

A system for determining maximum tolerated dose in clinical trial
由: Keying Ye, et al.
出版: (2021-10-01)

The Safety, Acceptability, and Feasibility of Single-Dose Rifampicin as Post-Exposure Chemoprophylaxis for Contacts of Leprosy Patients in Togo: A Mixed-Method Sequential Explanatory Study
由: Akila Wimima Bakoubayi, et al.
出版: (2024-11-01)